Although traditional prognostic factors, including PSA levels, tumor stage, Gleason score, and surgical margin status, are often used to predict outcomes after RP, biochemical recurrence (BCR) has still been shown to occur in 20–40% of patients within 10 years2. The gene discussed is KLK3; the disease is neoplasm.